Literature DB >> 22521235

Smoking and chronic rhinitis: effects of nasal irrigations with sulfurous-arsenical-ferruginous thermal water: A prospective, randomized, double-blind study.

Giancarlo Ottaviano1, Gino Marioni, Luciano Giacomelli, Fabio Biagio La Torre, Claudia Staffieri, Rosario Marchese-Ragona, Alberto Staffieri.   

Abstract

PURPOSE: Smoking is a self-destructive behavior that is known to induce remodeling of the lower airways, leading to squamous metaplasia, but little is known about its effects on the nose and paranasal sinuses. Nasal irrigations are often mentioned as measures for treating sinonasal inflammations. The purpose of our study was to compare the effects of nasal irrigations with sulfurous-arsenical-ferruginous thermal water or isotonic sodium chloride solution in smokers with nonallergic chronic rhinosinusitis, based on clinical and olfactory evidence.
MATERIALS AND METHODS: The present study was a prospective, randomized, double-blind study performed in a tertiary academic referral center. Seventy smokers with nonallergic chronic rhinitis were enrolled. Nasal endoscopy, rhinomanometry, nasal cytology, and odor threshold measurements were performed in subjects randomized to daily nasal irrigations with either thermal water or isotonic sodium chloride solution for 1 month.
RESULTS: Immediately after the treatment, the thermal water irrigations revealed a positive pharmacologic action, judging from a tendency toward lower nasal resistances (P = .07) and larger numbers of ciliated cells in the patients treated (P = .003). Endoscopic findings in the thermal water group were still better than in the control group a further 2 months later (P = .03).
CONCLUSIONS: Our results indicate that nasal irrigations with thermal water had a good effect on endoscopic objective signs, nasal resistances, and epithelial trophism.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521235     DOI: 10.1016/j.amjoto.2012.03.002

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  6 in total

Review 1.  The prevalence of olfactory dysfunction in chronic rhinosinusitis.

Authors:  Preeti Kohli; Akash N Naik; E Emily Harruff; Shaun A Nguyen; Rodney J Schlosser; Zachary M Soler
Journal:  Laryngoscope       Date:  2016-11-22       Impact factor: 3.325

Review 2.  The role of mineral elements and other chemical compounds used in balneology: data from double-blind randomized clinical trials.

Authors:  Carla Morer; Christian-François Roques; Alain Françon; Romain Forestier; Francisco Maraver
Journal:  Int J Biometeorol       Date:  2017-08-28       Impact factor: 3.787

Review 3.  Clinical Evidence of Type 2 Inflammation in Non-allergic Rhinitis with Eosinophilia Syndrome: a Systematic Review.

Authors:  Eugenio De Corso; Veronica Seccia; Giancarlo Ottaviano; Elena Cantone; Daniela Lucidi; Stefano Settimi; Tiziana Di Cesare; Jacopo Galli
Journal:  Curr Allergy Asthma Rep       Date:  2022-02-09       Impact factor: 4.806

Review 4.  Thermal water applications in the treatment of upper respiratory tract diseases: a systematic review and meta-analysis.

Authors:  Sarah Keller; Volker König; Ralph Mösges
Journal:  J Allergy (Cairo)       Date:  2014-06-01

5.  Gene and protein expression of CXCR4 in adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations.

Authors:  Monica Neri; Luigi Sansone; Luisa Pietrasanta; Aliaksei Kisialiou; Eloisa Cabano; Marina Martini; Matteo A Russo; Donatella Ugolini; Marco Tafani; Stefano Bonassi
Journal:  Immun Ageing       Date:  2018-02-27       Impact factor: 6.400

Review 6.  Saline nasal irrigations for chronic rhinosinusitis: From everyday practice to evidence-based medicine. An update.

Authors:  Manuele Casale; Antonio Moffa; Michele Cassano; Francesco Carinci; Michele Antonio Lopez; Eleonora Maria Consiglia Trecca; Sara Torretta; Vittorio Rinaldi; Lorenzo Pignataro
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.